Related references
Note: Only part of the references are listed.Decreased expression of ten-eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoides
T. Gambichler et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Loss of nuclear localization of TET2 in colorectal cancer
Yuji Huang et al.
CLINICAL EPIGENETICS (2016)
Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype
Kuo-Wang Tsai et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer
Norihisa Ichimura et al.
CANCER PREVENTION RESEARCH (2015)
Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer
Agnieszka Anna Rawluszko-Wieczorek et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Restored expression levels of TET1 decrease the proliferation and migration of renal carcinoma cells
Min Fan et al.
MOLECULAR MEDICINE REPORTS (2015)
Function and information content of DNA methylation
Dirk Schuebeler
NATURE (2015)
TET1 is a tumor suppressor of hematopoietic malignancy
Luisa Cimmino et al.
NATURE IMMUNOLOGY (2015)
TET1 is controlled by pluripotency-associated factors in ESCs and downmodulated by PRC2 in differentiated cells and tissues
Francesco Neri et al.
NUCLEIC ACIDS RESEARCH (2015)
Genetic alterations of DNA methylation machinery in human diseases
Tewfik Hamidi et al.
EPIGENOMICS (2015)
Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes
Lili Li et al.
EPIGENOMICS (2015)
Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3′-shore
Jong-Lyul Park et al.
ONCOTARGET (2015)
TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
F. Neri et al.
ONCOGENE (2015)
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
Michael Christoph Haffner et al.
Oncotarget (2015)
Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas
Lili Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
PRDM14 promotes active DNA demethylation through the Ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells
Naoki Okashita et al.
DEVELOPMENT (2014)
5-Hydroxymethylcytosine is a predominantly stable DNA modification
Martin Bachman et al.
NATURE CHEMISTRY (2014)
Connections between TET proteins and aberrant DNA modification in cancer
Yun Huang et al.
TRENDS IN GENETICS (2014)
Poly(ADP-ribosyl)ation is involved in the epigenetic control of TET1 gene transcription
Fabio Ciccarone et al.
ONCOTARGET (2014)
Suppression of TET1-Dependent DNA Demethylation Is Essential for KRAS-Mediated Transformation
Bo-Kuan Wu et al.
CELL REPORTS (2014)
Regulation of TET Protein Stability by Calpains
Yu Wang et al.
CELL REPORTS (2014)
Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives
Cornelia G. Spruijt et al.
CELL (2013)
MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling
Su Jung Song et al.
CELL (2013)
Role of Tet1 in erasure of genomic imprinting
Shinpei Yamaguchi et al.
NATURE (2013)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
Miao Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells
Francesco Neri et al.
GENOME BIOLOGY (2013)
Cancer research in an era when epigenetics is no longer epi-challenges and opportunities
Qian Tao
CHINESE JOURNAL OF CANCER (2013)
Nuclear Exclusion of TET1 Is Associated with Loss of 5-Hydroxymethylcytosine in IDH1 Wild-Type Gliomas
Tim Mueller et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
Jueng Soo You et al.
CANCER CELL (2012)
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation
Yotaro Kudo et al.
CANCER SCIENCE (2012)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Christine Guo Lian et al.
CELL (2012)
Tet family proteins and 5-hydroxymethylcytosine in development and disease
Li Tan et al.
DEVELOPMENT (2012)
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas
Zhaohui Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas
L. Li et al.
ONCOGENE (2012)
TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
Chih-Hung Hsu et al.
CELL REPORTS (2012)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
Seung-Gi Jin et al.
CANCER RESEARCH (2011)
Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain
Junjie U. Guo et al.
CELL (2011)
Mbd3/NURD Complex Regulates Expression of 5-Hydroxymethylcytosine Marked Genes in Embryonic Stem Cells
Ozlem Yildirim et al.
CELL (2011)
Tet1 Is Dispensable for Maintaining Pluripotency and Its Loss Is Compatible with Embryonic and Postnatal Development
Meelad M. Dawlaty et al.
CELL STEM CELL (2011)
Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia
N. Konstandin et al.
LEUKEMIA (2011)
TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity
Kristine Williams et al.
NATURE (2011)
Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells
Hao Wu et al.
NATURE (2011)
Epigenetic Silencing of a Proapoptotic Cell Adhesion Molecule, the Immunoglobulin Superfamily Member IGSF4, by Promoter CpG Methylation Protects Hodgkin Lymphoma Cells from Apoptosis
Paul G. Murray et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
Shinsuke Ito et al.
NATURE (2010)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers
Hongchuan Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
J Ying et al.
ONCOGENE (2006)
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
SB Baylin et al.
NATURE REVIEWS CANCER (2006)
Epigenetic changes in virus-associated human cancers
HP Li et al.
CELL RESEARCH (2005)
Inhibitors of histone deacetylase and DNA methyltransfcrase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure
K Ghoshal et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells
Q Tao et al.
HUMAN MOLECULAR GENETICS (2002)
The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the down-regulation of E-cadherin gene expression via activation of DNA methyltransferases
CN Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)